CRP and rheumatoid arthritis: In an open-label study in 30 patients with RA with inadequate response to csDMARDs and up to one bDMARD, auricular VNS decreased DAS28-CRP by 1.4 at week 12, and 16 (53%) patients achieved 20% improvement in American College of Rheumatology criteria (ACR20) [18].